🧪 UPDATED DAILY FROM CLINICALTRIALS.GOVSynced today

Find Clinical Trials for Your Rare Disease

10615+ recruiting trials across all rare diseases. Filter by phase, location, and condition.

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Showing 20 of 10615 recruiting trials

Phase 2RecruitingNCT06376669

Stereotactic Body Proton Therapy for Treatment of Primary Renal Cell Carcinoma

👨‍⚕️ Sherif Shaaban, MD, Johns Hopkins University📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06648486

Robot-assisted Training

👨‍⚕️ Fuzhen Yuan, Dr.📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06680661

ABBA CORD: dCBT w/ Abatacept for aGVHD Prophylaxis

👨‍⚕️ Leland Metheny, MD, University Hospitals Seidman Cancer Center, Case Comprehensive Cancer Center📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT06737718

Use of Eye Tracking to Study Social Perception Abnormalities in Children With Angelman Syndrome

👨‍⚕️ Nathalie MD, PhD Boddaert, Assistance Publique - Hôpitaux de Paris📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06849986

IO Combined With AI as First-line Treatment for Patients With Soft Tissue Sarcoma(TAIS)

🏥 Fudan University📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT06890520

Neurometabolic Profile of Individuals With Primary Mitochondrial Disease

🏥 Children's Hospital of Philadelphia📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06712823

An Extension Study to Evaluate Safety and Efficacy in Participants Treated With CRN04894

🏥 Crinetics Pharmaceuticals Inc.📍 9 sites📅 Started Feb 2025View details ↗
Phase 1, PHASE2RecruitingNCT06680128

A Study to Assess the Safety, Reactogenicity, and Immunogenicity of SK Japanese Encephalitis Messenger Ribonucleic Acid (mRNA) Vaccines (GBP560) in Healthy Adults

🏥 SK Bioscience Co., Ltd.📍 3 sites📅 Started Feb 2025View details ↗
RecruitingNCT06889818

Korean Joint Registry for Alzheimer's Treatment and Diagnostics (JOY-ALZ)

👨‍⚕️ Geon-ha Kim, Ewha Womans University Mokdong Hospital📍 3 sites📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06913725

An Exploratory Study to Evaluate the Efficacy and Safety of FCN-159 in Patients With Brain Arteriovenous Malformations

🏥 Xuanwu Hospital, Beijing📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06797297

A Study to Evaluate the Efficacy and Safety of IBI363 Monotherapy Compared to Pembrolizumab in Patients With Unresectable Locally Advanced or Metastatic Mucosal or Acral Melanoma Who Had Not Previously Received Systemic Therapy

🏥 Innovent Biologics (Suzhou) Co. Ltd.📍 31 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06878950

Early Feeds in Gastroschisis

👨‍⚕️ Nicole Cacho, DO, University of California, Davis📍 2 sites📅 Started Feb 2025View details ↗
RecruitingNCT06637137

Patient Blood Management in Patients Scheduled for Cardiac Surgery

👨‍⚕️ luciana Teofili, Phd, Fondazione Policlinico Gemelli, IRCCS📍 1 site📅 Started Feb 2025View details ↗
Phase 1RecruitingNCT06579144

Pharmacokinetic Comparison of Efanesoctocog Alfa vs Other EHL-rFVIII Products in Participants With Severe Haemophilia A

👨‍⚕️ Elena Santagostino, MD, Sobi AB📍 8 sites📅 Started Feb 2025View details ↗
Phase 3RecruitingNCT07080931

Efficacy and Safety of 5% Minoxidil Foam in Female Androgenetic Alopecia

🏥 Zhejiang Sunshine Mandi Pharmaceutical Co.,Ltd.📍 1 site📅 Started Feb 2025View details ↗
RecruitingNCT05485831

Epidyolex® in Lennox Gastaut, Dravet Syndrome and Tuberous Sclerosis Complex: an Observational Study in ITALY

🏥 Jazz Pharmaceuticals📍 18 sites📅 Started Feb 2025View details ↗
NARecruitingNCT06837246

A Clinical Trial to Assess Cognitive Effects of Cognitive Nutritional Supplement in General Population

🏥 Pharmavite LLC📍 1 site📅 Started Feb 2025View details ↗
Phase 4RecruitingNCT06603662

Systemic Oral Glucocorticoids for the Treatment of Acute Osteoarthritis Pain in the Emergency Department

👨‍⚕️ Brent Becker, MD, WellSpan Health📍 1 site📅 Started Feb 2025View details ↗
Phase 2RecruitingNCT06679634

Retinoblastoma Phase II Expanded Access Clinical Trial

🏥 Targeted Therapy Technologies, LLC📍 1 site📅 Started Feb 2025View details ↗
NARecruitingNCT06861465

EMPower Mechanisms

🏥 University of Alberta📍 1 site📅 Started Feb 2025View details ↗
← PreviousPage 145 of 531Next →

Get alerts when new trials open

Create a free account to follow conditions and receive trial notifications.

Create free account →